234 related articles for article (PubMed ID: 30997872)
21. Case report: reinitiating pembrolizumab treatment after small bowel perforation.
Beck TN; Kudinov AE; Dulaimi E; Boumber Y
BMC Cancer; 2019 Apr; 19(1):379. PubMed ID: 31018834
[TBL] [Abstract][Full Text] [Related]
22. A case of recurrent bilateral uveitis independently associated with dabrafenib and pembrolizumab therapy.
Taylor SC; Hrisomalos F; Linette GP; Rao PK
Am J Ophthalmol Case Rep; 2016 Jul; 2():23-25. PubMed ID: 29503892
[TBL] [Abstract][Full Text] [Related]
23. Pembrolizumab-associated autoimmune haemolytic anaemia.
Johnstone P; Khan O
BMJ Case Rep; 2019 Oct; 12(10):. PubMed ID: 31653618
[TBL] [Abstract][Full Text] [Related]
24. Pneumonitis: a serious adverse effect of PD-L1 inhibitors including pembrolizumab.
Rickard F; Hyams C; Low AT
BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29735504
[TBL] [Abstract][Full Text] [Related]
25. Cardiac tamponade in a patient with stage IV lung adenocarcinoma treated with pembrolizumab.
Khan AM; Munir A; Thalody V; Munshi MK; Mehdi S
Immunotherapy; 2019 Dec; 11(18):1533-1540. PubMed ID: 31815569
[TBL] [Abstract][Full Text] [Related]
26. Bilateral Corneal Graft Rejection Associated With Pembrolizumab Treatment.
Vanhonsebrouck E; Van De Walle M; Lybaert W; Kruse V; Roels D
Cornea; 2020 Nov; 39(11):1436-1438. PubMed ID: 32452986
[TBL] [Abstract][Full Text] [Related]
27. [A 76-year-old man with loss of vision and dementia].
Miyashita N; Imai H; Mori H; Kodera M; Shirai T; Mizuno Y
No To Shinkei; 1997 Aug; 49(8):773-82. PubMed ID: 9282374
[TBL] [Abstract][Full Text] [Related]
28. Pembrolizumab-induced myasthenia gravis: A fatal case report.
March KL; Samarin MJ; Sodhi A; Owens RE
J Oncol Pharm Pract; 2018 Mar; 24(2):146-149. PubMed ID: 28147928
[TBL] [Abstract][Full Text] [Related]
29. A case of severe Pembrolizumab-induced neutropenia.
Barbacki A; Maliha PG; Hudson M; Small D
Anticancer Drugs; 2018 Sep; 29(8):817-819. PubMed ID: 29889673
[TBL] [Abstract][Full Text] [Related]
30. Inflammatory Myopathy and Axonal Neuropathy in a Patient With Melanoma Following Pembrolizumab Treatment.
Diamantopoulos PT; Tsatsou K; Benopoulou O; Anastasopoulou A; Gogas H
J Immunother; 2017; 40(6):221-223. PubMed ID: 28498142
[TBL] [Abstract][Full Text] [Related]
31. Radiation myelitis after pembrolizumab administration, with favorable clinical evolution and safe rechallenge: a case report and review of the literature.
Carausu M; Beddok A; Langer A; Girard N; Bidard FC; Massiani MA; Ricard D; Cabel L
J Immunother Cancer; 2019 Nov; 7(1):317. PubMed ID: 31753021
[TBL] [Abstract][Full Text] [Related]
32. Polymyalgia rheumatica due to pembrolizumab therapy.
Iskandar A; Hwang A; Dasanu CA
J Oncol Pharm Pract; 2019 Jul; 25(5):1282-1284. PubMed ID: 30249155
[TBL] [Abstract][Full Text] [Related]
33. Lymphocytic gastritis induced by pembrolizumab in a patient with metastatic melanoma.
Yip RHL; Lee LH; Schaeffer DF; Horst BA; Yang HM
Melanoma Res; 2018 Dec; 28(6):645-647. PubMed ID: 30256271
[TBL] [Abstract][Full Text] [Related]
34. Acute Tubulointerstitial Nephritis: A Case Report on Rare Adverse Effect of Pembrolizumab.
Basnet S; Dhital R; Tharu B
Medicina (Kaunas); 2019 May; 55(5):. PubMed ID: 31117208
[TBL] [Abstract][Full Text] [Related]
35. Pembrolizumab-Induced Pancytopenia: A Case Report.
Atwal D; Joshi KP; Ravilla R; Mahmoud F
Perm J; 2017; 21():17-004. PubMed ID: 28746020
[TBL] [Abstract][Full Text] [Related]
36. Pembrolizumab Induced Ocular Hypotony With Near Complete Vision Loss, Interstitial Pulmonary Fibrosis and Arthritis.
Nguyen M; Islam MR; Lim SW; Sahu A; Tamjid B
Front Oncol; 2019; 9():944. PubMed ID: 31608234
[TBL] [Abstract][Full Text] [Related]
37. A Case of Melanoma-Associated Retinopathy, Uveitis, and Optic Neuritis Associated With Pembrolizumab, Managed With Topical, Intravitreal, and Intravenous Steroids.
Xie K; Kong C; Mehta MC
J Vitreoretin Dis; 2020 Jun; 4(3):220-226. PubMed ID: 37007447
[TBL] [Abstract][Full Text] [Related]
38. Diabetic ketoacidosis induced by a single dose of pembrolizumab.
Maamari J; Yeung SJ; Chaftari PS
Am J Emerg Med; 2019 Feb; 37(2):376.e1-376.e2. PubMed ID: 30361152
[TBL] [Abstract][Full Text] [Related]
39. Acral vascular necrosis associated with immune-check point inhibitors: case report with literature review.
Khaddour K; Singh V; Shayuk M
BMC Cancer; 2019 May; 19(1):449. PubMed ID: 31088420
[TBL] [Abstract][Full Text] [Related]
40. A severe case of neuro-Sjögren's syndrome induced by pembrolizumab.
Ghosn J; Vicino A; Michielin O; Coukos G; Kuntzer T; Obeid M
J Immunother Cancer; 2018 Oct; 6(1):110. PubMed ID: 30348223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]